It’s become somewhat of a parlor game to speculate on what Amazon is going to do to the healthcare industry. Everyone has an opinion, but no one really knows for sure what the company will do and since Amazon isn’t saying much all we have is conjuncture. However now that Amazon has made the deep dive into diabetes this effort will offer some clues as diabetes is the perfect test case for Amazon.
First let’s state the obvious diabetes has a huge and growing patient population. Second there isn’t one drug or device that cannot be . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.